VELAB is a healthcare practice in Dendermonde. Public Limited, started on 15 March 1990, 2 establishments.

What is the address of VELAB?

The registered office of VELAB is located at Hoogveld 10, 9200 Dendermonde.

Is VELAB still active?

Yes. According to the CBE (30 October 2026) VELAB is active, legal situation “Normale toestand”, started on 15 March 1990.

Is VELAB registered on Peppol?

Yes, VELAB is registered on the Peppol network with ID 0208:0440240636.

What is the enterprise number of VELAB?

The enterprise number of VELAB is BE0440240636.

When was VELAB founded?

VELAB was founded on 15 March 1990.

Who are the directors of VELAB?

According to the 2025 annual accounts, the directors of VELAB are: Frédéric DAUCHE, CAB Selas, Isabelle EIMER.

Is VELAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 March 1990; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did VELAB make in 2025?

VELAB posted a profit after taxes of € 783,409 in financial year 2025.

What is the revenue of VELAB?

In its most recent annual accounts (2025), VELAB reported revenue of € 2,144,216.

VELAB (Public Limited) - Dendermonde - BE0440240636

Dossier VELAB, printed on 30 October 2026 from databakkes.be/en/0440240636/velab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VELAB from Dendermonde, company number BE0440240636, closed financial year 2025 with a result of € 783,409 after tax. For that financial year VELAB recorded revenue of € 2.1 million and equity of € 468,079. Compared with financial year 2024, the result moved from € 943,499 to € 783,409. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Healthy

€ 468,079

▼ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 783,409

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1 million

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 900,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 190,434

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 60 days on average.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 2,036,954 Revenue 2022: € 2,036,954 First fiscal year in the series	€ 2,125,587 Revenue 2023: € 2,125,587 ▲ 4% vs 2022 (€ 2,036,954) Favourable step	€ 2,221,898 Revenue 2024: € 2,221,898 ▲ 5% vs 2023 (€ 2,125,587) Favourable step	€ 2,144,216 Revenue 2025: € 2,144,216 ▼ 3% vs 2024 (€ 2,221,898) Unfavourable step	▼ 3%
Profit after taxes	€ 800,757 Profit after taxes 2022: € 800,757 First fiscal year in the series	€ 840,880 Profit after taxes 2023: € 840,880 ▲ 5% vs 2022 (€ 800,757) Favourable step	€ 943,499 Profit after taxes 2024: € 943,499 ▲ 12% vs 2023 (€ 840,880) Favourable step	€ 783,409 Profit after taxes 2025: € 783,409 ▼ 17% vs 2024 (€ 943,499) Unfavourable step	▼ 17%
Equity	€ 450,289 Equity 2022: € 450,289 First fiscal year in the series	€ 491,170 Equity 2023: € 491,170 ▲ 9% vs 2022 (€ 450,289) Favourable step	€ 584,669 Equity 2024: € 584,669 ▲ 19% vs 2023 (€ 491,170) Favourable step	€ 468,079 Equity 2025: € 468,079 ▼ 20% vs 2024 (€ 584,669) Unfavourable step	▼ 20%
Total debts	€ 994,277 Total debts 2022: € 994,277 First fiscal year in the series	€ 928,805 Total debts 2023: € 928,805 ▼ 7% vs 2022 (€ 994,277) Favourable step	€ 1,022,513 Total debts 2024: € 1,022,513 ▲ 10% vs 2023 (€ 928,805) Unfavourable step	€ 1,114,243 Total debts 2025: € 1,114,243 ▲ 9% vs 2024 (€ 1,022,513) Unfavourable step	▲ 9%
Cash	€ 955,780 Cash 2022: € 955,780 First fiscal year in the series	€ 1,016,141 Cash 2023: € 1,016,141 ▲ 6% vs 2022 (€ 955,780) Favourable step	€ 1,111,369 Cash 2024: € 1,111,369 ▲ 9% vs 2023 (€ 1,016,141) Favourable step	€ 1,016,923 Cash 2025: € 1,016,923 ▼ 8% vs 2024 (€ 1,111,369) Unfavourable step	▼ 8%
Retained profit	€ 388,289 Retained profit 2022: € 388,289 First fiscal year in the series	€ 429,170 Retained profit 2023: € 429,170 ▲ 11% vs 2022 (€ 388,289) Favourable step	€ 522,669 Retained profit 2024: € 522,669 ▲ 22% vs 2023 (€ 429,170) Favourable step	€ 406,079 Retained profit 2025: € 406,079 ▼ 22% vs 2024 (€ 522,669) Unfavourable step	▼ 22%
Dividend	€ 800,000 Dividend 2022: € 800,000 First fiscal year in the series	€ 800,000 Dividend 2023: € 800,000 Unchanged (€ 800,000) Unchanged	€ 850,000 Dividend 2024: € 850,000 ▲ 6% vs 2023 (€ 800,000) Unchanged	€ 900,000 Dividend 2025: € 900,000 ▲ 6% vs 2024 (€ 850,000) Unchanged	▲ 6%
Balance sheet total	€ 1,444,566 Balance sheet total 2022: € 1,444,566 First fiscal year in the series	€ 1,419,975 Balance sheet total 2023: € 1,419,975 ▼ 2% vs 2022 (€ 1,444,566) Unchanged	€ 1,607,182 Balance sheet total 2024: € 1,607,182 ▲ 13% vs 2023 (€ 1,419,975) Unchanged	€ 1,582,322 Balance sheet total 2025: € 1,582,322 ▼ 2% vs 2024 (€ 1,607,182) Unchanged	▼ 2%

Key figures of VELAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VELAB?

What happened at VELAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Frédéric DAUCHE stepped down as director. NBB
2028 Isabelle EIMER stepped down as director. NBB
2026 CAB Selas stepped down as director. NBB
Jul 3, 2026 New annual accounts for financial year 2025: profit of € 783,409 (▼ 17% vs 2024). Source: NBB ↗
2024 Frédéric DAUCHE became a director. NBB
2022 CAB Selas became a director. NBB
2022 Isabelle EIMER became a director. NBB
Oct 5, 1990 New establishment in Herentals. KBO

In short

From € 800,757 profit in 2022 to € 783,409 profit in 2025.

Paid € 1.1 million in corporate taxes since 2022.

Best year ever: 2024, with € 943,499 profit.

Paid out € 3.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

CAB SELAS - Soc. d'excercice libéral par actions simplifiéé 100%

VELAB

The shares are held by CAB SELAS - Soc. d'excercice libéral par actions simplifiéé (100%).

Directors

According to the 2025 annual accounts

Frédéric DAUCHE

Director

Also active at: MEDISCH LABO MEDINA, CENTRUM VOOR MEDISCHE ANALYSE, ALGEMEEN KLINISCH LABO, LKO -LMC, MEDISEC

since 2024 · until 2028

CAB Selas

Director · represented by Jovana MOULARDE

Also active at: MACSYS

since 2022 · until 2026

Isabelle EIMER

Director

Also active at: Laboratoires réunis, MEDISCH LABO MEDINA, MACSYS, CENTRUM VOOR MEDISCHE ANALYSE, SOCIETE DE GESTION D'INVESTISSEMENT, DE CONSEIL ET DE REALISATION, ALGEMEEN KLINISCH LABO, LKO -LMC, MEDISEC

since 2022 · until 2028

Shareholders

CAB SELAS - Soc. d'excercice libéral par actions simplifiéé

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Hoogveld 10

9200 Dendermonde

2.047.974.262

Oud-Strijderslaan (HRT) 199

2200 Herentals

Active since 5 October 1990

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Klinisch Laboratorium Dendermonde

MEDISCH LABO MEDINA same network

€ 93.4 million revenue · 2025

MACSYS same network

€ 88.8 million revenue · 2025

CAB

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0440.240.636

VAT number

BE 0440.240.636

Registered office

Hoogveld 10, 9200 Dendermonde

Names & denominations

VELAB

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 March 1990

Peppol

Active · Active since 8 Jan 2026

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

VELAB

Financials

What happened to VELAB?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions